Table 2.
N = 37 | |
---|---|
Pathologic Stage | |
I | 4 (10.8%) |
II | 3 (8.1%) |
III | 4 (10.8%) |
IV | 15 (40.5%) |
Unknown | 11 (29.7%) |
Classification (cHL) | |
Nodular sclerosis | 8 (21.6%) |
Mixed cellularity | 19 (51.3%) |
Lymphocyte depleted | 1 (2.7%) |
Lymphocyte-rich | 2 (5.4%) |
Unknown | 7 (18.9%) |